Stocks and Investing Stocks and Investing
Mon, July 10, 2023
Sun, July 9, 2023
Fri, July 7, 2023
Thu, July 6, 2023
Wed, July 5, 2023

Oren Livnat Reiterated (AVDL) at Strong Buy with Increased Target to $21 on, Jul 5th, 2023


Published on 2024-10-28 04:38:11 - WOPRAI, Oren Livnat
  Print publication without navigation


Oren Livnat of HC Wainwright & Co., Reiterated "Avadel Pharmaceuticals plc" (AVDL) at Strong Buy with Increased Target from $18 to $21 on, Jul 5th, 2023.

Oren has made no other calls on AVDL in the last 4 months.



There are 4 other peers that have a rating on AVDL. Out of the 4 peers that are also analyzing AVDL, 0 agree with Oren's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Oren


  • Ami Fadia of "Needham" Reiterated at Strong Buy and Held Target at $18 on, Friday, June 30th, 2023
  • Francois Brisebois of "Oppenheimer" Maintained at Buy with Increased Target to $25 on, Friday, June 30th, 2023
  • Matthew Kaplan of "Ladenburg Thalmann" Maintained at Strong Buy with Increased Target to $16 on, Tuesday, May 2nd, 2023
  • Patrick Dolezal of "LifeSci Capital" Maintained at Buy with Increased Target to $26 on, Tuesday, May 2nd, 2023